No definition available.
Pneumonia due to other infectious organisms, not elsewhere classified
DOID EFO Endpoint Browser PheWeb
J10_PNEUMONONBACT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1189 |
4. Check minimum number of eventsNone |
1189 |
5. Include endpointsNone |
1189 |
6. Filter based on genotype QC (FinnGen only) |
1189 |
Control definitions (FinnGen only)
- Control exclude
- J10_INFLUPNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Pneumonia due to other infectious organisms, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- All pneumoniae
- Influenza and pneumonia
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9869 | 4313 | 5437 |
| Only index persons | 7295 | 3334 | 3961 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.14 | 0.12 | 0.15 |
| Only index persons | 0.14 | 0.12 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 55.32 | 52.82 | 57.02 |
| Only index persons | 43.09 | 42.06 | 43.96 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1189 | 567 | 622 |
| Unadjusted period prevalence (%) | 0.24 | 0.19 | 0.27 |
| Median age at first event (years) | 56.29 | 49.76 | 62.24 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1058
- Matched controls
- 10578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J18.9
ICD-10 Finland
Pneumonia, unspecified
43.2
323.0
536
245
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
323.0
367
*
TGC00
NOMESCO Finland
Bronchial lavation
42.2
187.5
235
71
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
1953.9
170.6
161
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
81.9
169.7
189
28
48399
ICD-8 Finland
Pneumonia due to other specified organism
+∞
152.9
143
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
13.5
150.7
280
275
4830A
ICD-9 Finland
Pneumonia due to other specified organism, Mycoplasma pneumoniae[PNEUMONIA E MYCOPLASMA PNEUMONIAE]
+∞
136.5
128
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
16.8
130.0
216
159
R50.9
ICD-10 Finland
Fever, unspecified
6.8
112.4
325
648
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.1
105.1
224
274
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.8
97.1
245
393
H02AB06
ATC
prednisolone; systemic
3.9
93.9
658
3149
J16.0
ICD-10 Finland
Chlamydial pneumonia
+∞
92.0
87
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.0
91.7
176
173
4830X
ICD-9 Finland
Pneumonia due to other specified organism, Mycoplasma pneumoniae[PNEUMONIA ALIA DEFINITA]
+∞
76.0
72
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.5
74.6
214
400
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
71.9
582
2876
ZX108
NOMESCO Finland
Inhalation
46.1
62.9
77
18
J01MA14
ATC
moxifloxacin; systemic
6.7
62.3
170
293
XW000
NOMESCO Finland
Bone marrow biopsy
9.5
61.9
133
158
J01MA12
ATC
levofloxacin; systemic
4.0
60.7
287
903
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
13.0
57.9
105
89
WW500
NOMESCO Finland
Blood transfusion
9.2
56.7
124
151
ZX120
NOMESCO Finland
Intravenous
5.2
56.1
192
435
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.6
55.7
127
166
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
52.7
247
760
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.7
52.3
110
125
L03AA02
ATC
filgrastim; parenteral
12.0
51.2
96
87
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
50.4
48
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.7
49.8
153
303
GD1AD
NOMESCO Finland
Thorax CT examination
9.6
49.7
105
120
JN4BD
NOMESCO Finland
Extensive body CT
4.2
47.7
200
551
JN4AD
NOMESCO Finland
Body CT examination
5.2
46.9
157
343
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
43.0
397
1934
J01FF01
ATC
clindamycin; systemic
2.8
42.5
361
1673
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.7
42.4
113
185
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
13.6
42.1
74
58
A04AA01
ATC
ondansetron; systemic, rectal
5.4
41.7
134
278
C03CA01
ATC
furosemide; systemic
2.7
41.5
356
1655
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
41.2
288
1174
L04AA06
ATC
mycophenolic acid; systemic
15.4
40.8
68
47
H02AB02
ATC
dexamethasone; systemic
4.2
40.0
168
459
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
+∞
39.8
38
*
Z51.5
ICD-10 Finland
Palliative care
6.0
39.5
114
207
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.9
38.4
63
42
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.4
38.3
122
250
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
11.0
37.1
72
70
M04AA01
ATC
allopurinol; systemic
3.3
36.7
206
714
127
Kela drug reimbursment
Transplant complication
16.5
35.9
58
37
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.3
35.7
115
238
L04AX01
ATC
azathioprine; systemic
6.1
35.6
101
179
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
35.0
273
1177
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.9
35.0
82
111
L03AA13
ATC
pegfilgrastim; parenteral
7.3
34.9
87
129
N02AA05
ATC
oxycodone; systemic
3.3
34.7
200
703
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
27.2
34.4
47
18
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.8
34.1
89
141
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
39.7
33.6
42
11
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.6
33.4
165
515
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
33.3
196
699
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
13.3
32.9
58
46
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
32.0
192
692
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
32.0
557
3581
48609
ICD-8 Finland
Pneumonia, unspecified
+∞
31.4
30
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.4
30.5
64
72
R03AC02
ATC
salbutamol; inhalant
2.1
30.4
563
3685
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
12.9
30.3
54
44
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.2
29.5
118
305
A02BC02
ATC
pantoprazole; systemic
2.1
29.3
700
5069
R03BB04
ATC
tiotropium bromide; inhalant
3.9
28.9
127
357
R06.0
ICD-10 Finland
Dyspnoea
2.4
27.6
292
1465
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
27.5
216
921
1CX01
NOMESCO Finland
NA
+∞
27.2
26
*
B59
ICD-10 Finland
Pneumocystosis
+∞
27.2
26
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
11.3
27.0
51
47
R81
ICPC
Pneumonia
10.3
26.7
53
54
L04AD01
ATC
ciclosporin; systemic
9.9
26.7
54
57
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.6
26.7
226
1003
A04AA02
ATC
granisetron; systemic, transdermal
4.1
25.8
106
280
J45.9
ICD-10 Finland
Asthma, unspecified
2.7
25.7
202
858
H02AB07
ATC
prednisone; oral
2.8
24.7
181
735
J05AB11
ATC
valaciclovir; oral
2.8
24.3
173
691
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
29.9
24.2
32
11
J02AC03
ATC
voriconazole; systemic
57.4
24.1
28
5
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
88.8
23.8
26
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
14.3
23.7
40
29
H02AB04
ATC
methylprednisolone; systemic
2.6
22.9
184
789
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
22.3
373
2252
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.9
22.2
74
159
ZX112
NOMESCO Finland
Subcutaneous
7.6
22.2
52
71
A41.9
ICD-10 Finland
Sepsis, unspecified
5.9
22.1
63
113
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.7
21.8
64
119
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
21.6
318
1818
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.2
21.6
121
411
TK800
NOMESCO Finland
Hemodialysis
8.0
21.5
49
64
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
34.6
21.2
27
8
WW300
NOMESCO Finland
Transfer of autologic stem cells
51.1
21.2
25
5
J01FA06
ATC
roxithromycin; oral
1.9
20.9
418
2685
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
13.3
20.8
36
28
L04AA01
ATC
[U] ciclosporin; systemic
10.6
20.7
40
39
Z94.0
ICD-10 Finland
Kidney transplant status
12.8
20.5
36
29
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.3
20.3
63
125
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.8
20.0
46
61
B03XA01
ATC
erythropoietin; parenteral
15.7
19.8
32
21
H02AB09
ATC
hydrocortisone; systemic
7.8
19.5
45
60
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.0
19.2
79
209
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.2
19.2
105
350
A46
ICD-10 Finland
Erysipelas
2.5
18.9
162
714
ZXD05
NOMESCO Finland
Urgent procedure
1.9
18.9
333
2026
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.8
18.8
83
234
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
11.3
18.8
35
32
1XC02
NOMESCO Finland
NA
17.5
18.8
29
17
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
18.6
128
497
J16
ICD-10 Finland
Pneumonia due to other infectious organisms, not elsewhere classified
193.2
18.6
19
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
6.0
18.2
50
86
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.0
18.1
74
195
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.7
18.1
33
29
WX892
NOMESCO Finland
Monitored bed care
3.2
18.0
100
335
A07EC01
ATC
sulfasalazine; oral, rectal
3.0
17.9
107
379
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
17.9
412
2740
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
14.9
17.7
29
20
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.8
17.5
44
67
L03AA14
ATC
lipegfilgrastim; parenteral
6.6
17.5
45
71
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
15.1
17.2
28
19
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
17.2
142
613
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
8.8
17.0
36
42
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.2
17.0
35
39
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
17.0
241
1339
A03
ICPC
Fever
2.3
16.9
163
761
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.7
16.9
49
90
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
16.8
145
641
XG410
NOMESCO Finland
Flow-volume spirometry
4.3
16.7
63
154
J01DB01
ATC
cefalexin; oral
1.9
16.6
835
7040
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.2
16.5
91
305
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.4
16.5
43
69
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
16.5
386
2561
B03XA02
ATC
darbepoetin alfa; parenteral
7.5
16.3
38
52
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
11.4
16.3
30
27
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.5
16.2
42
67
A12AA04
ATC
calcium carbonate; oral
8.7
16.0
34
40
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
8.7
16.0
34
40
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.0
16.0
96
341
Z2446
NOMESCO Finland
Social worker
3.3
15.9
84
273
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.2
15.9
61
152
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
15.6
418
2883
J12.8
ICD-10 Finland
Other viral pneumonia
86.4
15.6
17
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
15.4
122
513
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.4
15.3
76
236
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
15.3
213
1167
N02AX02
ATC
tramadol; systemic, rectal
1.7
15.3
428
2985
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.9
15.3
32
37
J96.0
ICD-10 Finland
Acute respiratory failure
13.3
15.2
26
20
N03AX16
ATC
pregabalin; oral
2.0
15.2
240
1380
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
12.0
15.1
27
23
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.6
15.0
32
38
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.4
14.8
32
39
M05BX04
ATC
denosumab; parenteral
3.7
14.7
64
179
N02BE01
ATC
paracetamol; systemic, rectal
1.9
14.7
864
7462
A11CC03
ATC
alfacalcidol; systemic
5.8
14.6
41
73
L01BB05
ATC
fludarabine; systemic
+∞
14.6
14
*
WX726
NOMESCO Finland
High-flow oxygen therapy
+∞
14.6
14
*
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
+∞
14.6
14
*
390
Kela drug reimbursment
Ibrutinib
81.2
14.6
16
*
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
14.5
130
583
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
152.0
14.5
15
*
P01BA02
ATC
hydroxychloroquine; oral
2.8
14.4
96
365
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
14.4
99
383
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
27.6
14.3
19
7
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
9.9
14.2
28
29
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
13.6
14.2
24
18
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.6
14.2
36
56
B01AB05
ATC
enoxaparin; parenteral
1.8
14.1
306
1960
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.9
14.1
87
315
J05AB01
ATC
aciclovir; systemic
2.0
14.1
220
1255
J01CA04
ATC
amoxicillin; systemic
1.7
14.1
799
6752
XX3DW
NOMESCO Finland
Time consuming IT work
2.4
14.1
120
526
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
14.0
121
531
J47
ICD-10 Finland
Bronchiectasis
8.3
13.8
30
37
J01MA02
ATC
ciprofloxacin; systemic
1.7
13.7
395
2754
WW200
NOMESCO Finland
Immunization
4.9
13.6
44
93
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.8
13.5
87
324
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
13.5
114
497
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.2
13.4
41
81
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
18.5
13.4
20
11
WX002
NOMESCO Finland
Sedation and analgesia
2.0
13.4
202
1138
B01AB10
ATC
tinzaparin; parenteral
2.9
13.3
85
314
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
40.6
13.2
16
*
J01AA02
ATC
doxycycline; systemic
1.7
13.1
775
6541
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
13.0
170
904
JN6AD
NOMESCO Finland
CT of torso and neck
8.0
12.6
28
36
1512
Kela drug reimbursment
Ibrutinib
70.7
12.6
14
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
10.2
12.5
24
24
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.4
12.5
37
71
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.1
12.5
48
121
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
12.5
117
536
YNB10
NOMESCO Finland
Collection of stem cells for transplant
131.5
12.5
13
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
12.3
280
1810
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
38.0
12.2
15
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
12.1
166
899
N05CF01
ATC
zopiclone; oral
1.7
12.0
306
2042
A06AD11
ATC
lactulose; oral
2.1
11.9
136
683
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
11.9
11.8
21
18
C90.0
ICD-10 Finland
Multiple myeloma
10.7
11.8
22
21
C83.1
ICD-10 Finland
Mantle cell lymphoma
16.6
11.7
18
11
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.1
11.7
45
114
WX720
NOMESCO Finland
Own respiration
3.5
11.6
54
161
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
11.6
72
263
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.3
11.6
30
49
WX882
NOMESCO Finland
High dependency care
4.4
11.6
41
96
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
11.5
66
228
AA1AD
NOMESCO Finland
CT of head and brain
1.8
11.5
227
1397
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
11.5
90
377
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
11.5
165
911
J17.2*B44.0
ICD-10 Finland
Pneumonia in invasive aspergillosis
+∞
11.5
11
*
48509
ICD-8 Finland
Bronchopneumonia, unspecified
+∞
11.5
11
*
L01XE27
ATC
[U] ibrutinib; oral
121.3
11.4
12
*
R03BA02
ATC
budesonide; inhalant
1.9
11.4
169
943
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
8.4
11.3
24
29
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
11.3
264
1710
E0000UV
ATC
NA
1.6
11.3
371
2646
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
35.4
11.3
14
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.9
11.3
45
118
J46
ICD-10 Finland
Status asthmaticus
5.8
11.2
31
55
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.5
11.2
88
370
B02.9
ICD-10 Finland
Zoster without complication
2.8
11.2
71
264
L01AA01
ATC
cyclophosphamide; systemic
25.3
11.2
15
6
R4110
NOMESCO Finland
Physiotherapy
1.7
11.1
259
1679
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.1
11.0
42
106
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
10.9
102
466
J45.1
ICD-10 Finland
Nonallergic asthma
2.9
10.8
67
244
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
10.8
177
1022
137
Kela drug reimbursment
Uraemia requiring dialysis
10.7
10.8
20
19
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
60.6
10.6
12
*
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
60.6
10.6
12
*
ZXE00
NOMESCO Finland
One hour or less
1.6
10.6
389
2841
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
11.4
10.6
19
17
WX725
NOMESCO Finland
Noninvasive ventilation
3.1
10.5
56
186
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
10.4
55
181
A07AA09
ATC
vancomycin; oral
7.8
10.4
23
30
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.9
10.4
41
107
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
32.9
10.3
13
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
8.9
10.3
21
24
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.8
10.3
43
118
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
10.3
79
328
WZC30
NOMESCO Finland
Teaching
2.0
10.3
137
734
D69.5
ICD-10 Finland
Secondary thrombocytopenia
23.6
10.3
14
6
N05BA06
ATC
lorazepam; systemic, sublingual
3.1
10.2
56
189
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
10.2
37
89
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
5.1
10.2
31
62
SPAT1255
SPAT
Intravenous administration of medicine
2.6
10.2
76
311
A04AA55
ATC
palonosetron, combinations; systemic
4.0
10.2
40
104
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
10.1
92
416
R53
ICD-10 Finland
Malaise and fatigue
1.8
10.1
188
1131
M01CB01
ATC
sodium aurothiomalate; parenteral
6.2
10.0
26
43
JN4CD
NOMESCO Finland
Very extensive body CT
3.4
10.0
47
142
UJF32
NOMESCO Finland
Coloscopy
1.7
10.0
246
1615
N18.8
ICD-10 Finland
Other chronic renal failure
4.1
9.9
37
92
153
Kela drug reimbursment
Lenalidomid
16.9
9.9
15
9
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.3
9.9
29
56
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
20.2
9.8
14
7
J20
ICD-10 Finland
Acute bronchitis
2.3
9.7
94
437
J96.1
ICD-10 Finland
Chronic respiratory failure
5.9
9.7
26
45
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
13.5
9.7
16
12
Z94.2
ICD-10 Finland
Lung transplant status
55.5
9.7
11
*
N05BA04
ATC
oxazepam; oral
1.7
9.5
233
1522
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
9.5
173
1034
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
6.7
9.5
23
35
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
100.9
9.4
10
*
J15.8
ICD-10 Finland
Other bacterial pneumonia
30.3
9.4
12
*
J17.2*B37.1
ICD-10 Finland
Pneumonia in candidiasis
+∞
9.4
9
*
J17.2*B44.1
ICD-10 Finland
Pneumonia in other aspergillosis
+∞
9.4
9
*
RD210
NOMESCO Finland
NA
4.9
9.3
29
60
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.4
9.3
32
74
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.7
9.3
63
245
M05BA04
ATC
alendronic acid; oral
2.4
9.2
79
348
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.3
9.2
45
141
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.8
9.2
37
99
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
6.8
9.2
22
33
TGD00
NOMESCO Finland
Needle biopsy of lung
15.7
9.0
14
9
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
9.0
208
1333
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
9.0
138
774
WF004
NOMESCO Finland
Palliative radiotherapy
4.6
9.0
30
67
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
9.0
172
1040
J02AC01
ATC
fluconazole; systemic
1.5
8.9
345
2530
TAB00
NOMESCO Finland
Lumbar puncture
2.9
8.9
53
191
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
4.6
8.8
29
64
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.8
8.8
36
98
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
6.0
8.8
23
39
WX722
NOMESCO Finland
PEEP
3.0
8.7
50
174
L04AA13
ATC
leflunomide; oral
3.8
8.7
35
94
J18
ICD-10 Finland
Pneumonia, organism unspecified
11.7
8.6
15
13
L01AA02
ATC
chlorambucil; oral
16.4
8.6
13
8
L04AX04
ATC
lenalidomide; oral
16.4
8.6
13
8
Z3231
NOMESCO Finland
Registered nurse
1.6
8.5
265
1841
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
27.7
8.5
11
*
6BA02
NOMESCO Finland
NA
27.7
8.5
11
*
R05
ICD-10 Finland
Cough
1.7
8.5
180
1127
ZX131
NOMESCO Finland
Intrathecal
90.7
8.4
9
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
90.7
8.4
9
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
90.7
8.4
9
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
90.7
8.4
9
*
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
7.9
8.4
18
23
1AA09
NOMESCO Finland
NA
+∞
8.3
8
*
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
+∞
8.3
8
*
J17.2
ICD-10 Finland
Pneumonia in mycoses
+∞
8.3
8
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.7
8.3
27
59
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
5.3
8.3
24
46
R28
ICPC
Limited function/disability (R)
8.6
8.3
17
20
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.1
8.3
43
141
A41.8
ICD-10 Finland
Other specified sepsis
5.6
8.3
23
42
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
5.9
8.3
22
38
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
8.3
63
259
P01AB01
ATC
metronidazole; oral, rectal
1.5
8.3
358
2681
B05DA
ATC
Isotonic solutions
10.8
8.3
15
14
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
10.8
8.3
15
14
WW409
NOMESCO Finland
Other aferesis
14.6
8.2
13
9
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.0
8.2
31
79
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
8.2
88
429
N18.0
ICD-10 Finland
End-stage renal disease
6.1
8.2
21
35
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
8.1
155
938
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
8.1
38
116
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
8.2
8.1
17
21
R06AE07
ATC
cetirizine; oral
1.5
8.1
397
3053
B05DB
ATC
Hypertonic solutions
11.8
8.1
14
12
GD2SN
NOMESCO Finland
Lung ventilation SPECT
10.1
8.0
15
15
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
22.2
8.0
11
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
7.9
314
2301
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
13.1
7.9
13
10
R03DC03
ATC
montelukast; oral
1.8
7.9
138
814
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
7.9
118
658
GD1UN
NOMESCO Finland
Lung circulation SPECT
10.9
7.8
14
13
R04.2
ICD-10 Finland
Haemoptysis
3.4
7.8
36
109
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
9.5
7.8
15
16
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.9
7.8
24
50
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
7.8
130
754
A07AA02
ATC
nystatin; oral
2.4
7.8
63
270
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.1
7.7
23
46
J01FA10
ATC
azithromycin; systemic
1.4
7.7
535
4394
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
45.3
7.7
9
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
45.3
7.7
9
*
A28
ICPC
Limited function/disability NOS
1.8
7.7
129
748
ZY010
NOMESCO Finland
Hospital outpatient
2.7
7.7
50
191
R11
ICD-10 Finland
Nausea and vomiting
2.2
7.6
75
351
R03BA05
ATC
fluticasone; inhalant
1.7
7.6
166
1044
M31.3
ICD-10 Finland
Wegener granulomatosis
18.5
7.6
11
6
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
18.5
7.6
11
6
V03AE02
ATC
sevelamer; oral
11.9
7.6
13
11
R03BA08
ATC
ciclesonide; inhalant
2.1
7.6
82
403
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
7.6
68
308
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.0
7.6
43
148
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
25.2
7.6
10
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
25.2
7.6
10
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
25.2
7.6
10
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.5
7.5
25
57
SPAT1262
SPAT
Handing over of treatment supplies
1.7
7.4
169
1074
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
80.6
7.4
8
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
7.4
424
3348
V03AE03
ATC
lanthanum carbonate; oral
13.5
7.4
12
9
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.4
7.4
33
98
N06AA09
ATC
amitriptyline; systemic
2.0
7.3
93
488
J01DA01
ATC
[U] cefalexin; systemic
1.4
7.3
590
4964
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
8.4
7.3
15
18
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
6.9
7.3
17
25
B44.9
ICD-10 Finland
Aspergillosis, unspecified
+∞
7.3
7
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
7.3
7
*
47099
ICD-8 Finland
Influenza, unqualified
+∞
7.3
7
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.2
7.3
21
41
C07AB07
ATC
bisoprolol; oral
1.4
7.2
431
3424
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
7.2
65
294
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
7.2
50
198
SPAT1263
SPAT
Sampling
1.4
7.2
394
3082
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
30.2
7.2
9
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
30.2
7.2
9
*
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
8.0
7.1
15
19
49300
ICD-8 Finland
Asthma, bronchiale
3.9
7.1
27
70
196
Kela drug reimbursment
Paricalcitol and cinacalcet
12.1
7.1
12
10
Z3226
NOMESCO Finland
Physiotherapist
1.7
7.1
170
1099
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.4
7.1
24
56
R4190
NOMESCO Finland
Nutritional therapy
3.2
7.0
35
113
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.7
7.0
46
177
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
6.9
52
215
ZXA00
NOMESCO Finland
Right side
1.5
6.9
248
1771
M10.9
ICD-10 Finland
Gout, unspecified
2.2
6.9
66
310
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.6
6.9
48
191
R03AK08
ATC
formoterol and beclometasone; inhalant
3.0
6.8
36
121
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
8.3
6.8
14
17
R03BA01
ATC
beclometasone; inhalant
1.8
6.8
127
762
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
6.2
6.8
17
28
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
40.3
6.8
8
*
L01EL01
ATC
ibrutinib; oral
40.3
6.8
8
*
RS220
NOMESCO Finland
NA
4.7
6.7
21
45
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.2
6.7
33
106
WW400
NOMESCO Finland
Plasmaferesis
22.7
6.7
9
*
TQW80
NOMESCO Finland
Local dermatologic skincare
3.5
6.6
29
85
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.4
6.6
51
215
ZX100
NOMESCO Finland
Oral
4.6
6.6
21
46
205
Kela drug reimbursment
Chronic hypertension
1.5
6.6
256
1858
S18
ICPC
Laceration/cut
1.4
6.6
391
3087
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
12.3
6.6
11
9
L04AX05
ATC
pirfenidone; oral
12.3
6.6
11
9
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
6.6
58
260
B34.9
ICD-10 Finland
Viral infection, unspecified
3.4
6.6
29
86
E87.5
ICD-10 Finland
Hyperkalaemia
4.8
6.6
20
42
284
Kela drug reimbursment
Nintedanib and pirfenidone
10.1
6.5
12
12
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.3
6.5
31
97
R02
ICPC
Shortness of breath/dyspnoea
1.8
6.5
107
616
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.0
6.5
24
61
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.2
6.5
16
26
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
6.4
72
361
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
70.3
6.4
7
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
70.3
6.4
7
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
70.3
6.4
7
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
70.3
6.4
7
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.4
6.4
52
225
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.8
6.4
38
138
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.1
6.4
23
57
R03DA04
ATC
theophylline; systemic, rectal
2.6
6.4
45
179
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
3.8
6.4
25
67
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
6.4
51
217
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
6.6
6.3
15
23
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
6.3
132
819
N17.8
ICD-10 Finland
Other acute renal failure
6.0
6.3
16
27
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
5.6
6.3
17
31
R03AC03
ATC
terbutaline; inhalant
1.7
6.3
121
735
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
11.1
6.3
11
10
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.9
6.3
24
63
WX110
NOMESCO Finland
Local anesthesy
1.4
6.3
643
5575
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.2
6.3
30
95
4809X
ICD-9 Finland
Viral pneumonia, unspecified
+∞
6.3
6
*
J02AC04
ATC
posaconazole; systemic
+∞
6.3
6
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
26.8
6.2
8
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.5
6.2
47
195
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.7
6.2
25
69
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.9
6.2
36
129
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
6.2
80
425
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
6.1
31
102
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
6.1
45
186
R51.80
ICD-10 Finland
Headache
1.7
6.1
121
741
SPAT1301
SPAT
No procedures
1.5
6.1
284
2135
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
6.1
76
400
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
4.9
6.1
18
37
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
6.1
57
263
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.0
6.0
32
109
R03AC12
ATC
salmeterol; inhalant
2.7
6.0
39
148
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.8
6.0
36
132
UDC00
NOMESCO Finland
Ear microscopy
2.0
6.0
71
364
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.0
181
1237
3AC01
NOMESCO Finland
NA
5.6
6.0
16
29
C82.1
ICD-10 Finland
Follicular lymphoma grade II
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
188
52
42.76
307.81
2.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
313
121
34.75
307.65
2.8
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
260
67
49.39
307.65
2.1
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
262
92
36.24
307.65
2.7
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
313
226
18.44
307.65
3.4
2.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
230
74
38.30
307.65
2.2
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
229
66
42.74
307.65
2.4
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
296
85
46.03
307.65
2.1
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
226
64
43.37
307.65
2.2
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
288
145
25.89
307.65
7.0
5.1
iu/ml
350.7
462.1
0.23
59
18
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
378
35
157.87
307.65
2.0
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
322
124
35.24
307.65
2.7
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
156
15
119.55
306.63
1.4
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
227
135
20.55
281.42
1.9
1.3
—
—
—
0
0
(44790048)
171
56
35.50
266.19
2.3
1.3
—
—
—
0
0
(44790047)
171
56
35.50
266.19
2.3
1.3
—
—
—
0
0
(44806118)
171
56
35.50
266.19
2.3
1.3
—
—
—
0
0
(44790049)
171
56
35.50
266.19
2.3
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
203
113
21.46
258.93
3.7
2.9
u/ml
1094.7
6402.7
—
16
6
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
514
1164
7.02
235.65
3.8
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
426
801
7.73
234.54
3.3
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
116
11
116.75
227.37
1.3
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
153
63
27.72
219.94
3.1
2.2
e9/l
1.0
1.1
0.46
113
31
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
409
799
7.28
215.38
3.2
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
141
59
26.98
201.19
2.5
2.0
%
26.3
43.5
2.76
13
11
(3023368) Bacteria identified in Blood by Culture
652
2090
5.69
197.73
10.6
3.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
135
56
27.07
193.12
2.8
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
126
44
31.91
191.20
2.5
2.2
%
13.1
13.5
0.05
47
19
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
138
63
24.65
190.29
2.8
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
125
45
30.92
187.77
2.6
2.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
230
269
10.36
187.18
3.0
1.7
ug/l
0.8
2.5
0.92
211
234
(3005719) IgG [Mass/volume] in Serum or Plasma
330
616
7.03
179.08
5.9
2.5
g/l
8.4
10.8
13.17
320
563
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
109
30
39.90
177.13
2.5
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
102
24
46.39
172.27
2.5
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
102
24
46.39
172.27
2.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
109
38
31.48
165.15
2.6
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
129
72
19.98
162.84
3.3
2.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
104
43
26.41
148.38
3.7
3.3
%
32.9
41.7
0.91
34
11
(3042936) Bacteria identified in Isolate by Culture
434
1224
5.01
146.62
2.5
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
367
917
5.34
143.07
10.8
3.6
u/l
268.5
244.7
1.39
356
871
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
109
56
21.33
142.50
3.3
1.9
e6/l
478.7
660.5
1.21
38
24
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
103
52
21.59
135.58
3.1
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
103
52
21.59
135.58
3.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
103
52
21.59
135.58
3.1
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
130
104
13.91
135.41
3.0
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
376
1030
4.88
129.93
2.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
80
23
37.22
127.96
2.1
2.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
80
23
37.22
127.96
2.2
2.1
%
6.3
6.0
0.05
80
23
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
73
18
43.14
121.41
2.3
2.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
292
689
5.29
119.99
8.8
3.9
%
1.2
0.9
1.16
181
195
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
261
563
5.66
118.68
2.7
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
243
491
5.96
118.64
2.7
1.6
g/l
1.1
1.4
2.00
220
459
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
88
47
20.14
112.75
3.5
2.1
e6/l
482.0
416.5
0.48
79
37
(3028433) Virus identified in Specimen by Culture
76
28
28.93
112.54
1.4
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
69
22
33.23
106.91
1.5
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
106
90
12.83
106.07
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
102
82
13.51
105.52
1.4
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
402
1370
3.92
100.56
7.1
3.1
mmol/l
0.8
0.8
1.72
382
1282
(3042111) Morphology [Interpretation] in Bone marrow Narrative
115
125
10.08
97.22
2.2
1.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
353
1127
4.03
96.52
13.1
5.0
mmol/l
1.1
1.0
1.59
336
1039
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
82
53
16.54
95.66
3.7
3.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
177
323
6.26
95.25
2.7
1.5
u/ml
10.9
10.7
—
10
8
(3019069) Monocytes/100 leukocytes in Blood
773
4147
3.47
91.96
18.5
5.6
%
8.7
8.7
0.11
750
3864
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
149
238
7.01
91.25
1.8
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
799
4412
3.47
89.81
15.8
5.2
e9/l
0.0
0.0
0.85
740
3797
(3006504) Eosinophils/100 leukocytes in Blood
766
4126
3.41
89.69
17.5
5.3
%
2.3
2.9
11.94
741
3819
(3001604) Monocytes [#/volume] in Blood
796
4390
3.46
89.56
15.8
5.2
e9/l
0.7
0.6
1.46
737
3779
(3022096) Basophils/100 leukocytes in Blood
749
4003
3.35
88.40
17.1
5.5
%
0.6
0.7
2.09
728
3712
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
65
30
22.86
88.34
1.5
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
778
4264
3.39
87.77
17.7
5.5
%
25.4
28.3
7.23
756
3951
(3002179) Metamyelocytes/100 leukocytes in Blood
241
623
4.60
86.80
8.7
3.7
%
0.6
0.5
0.72
128
139
(3018010) Neutrophils/100 leukocytes in Blood
769
4203
3.35
86.80
16.1
5.3
%
59.5
56.9
5.46
747
3917
(3019198) Lymphocytes [#/volume] in Blood
805
4528
3.41
86.41
16.0
5.3
e9/l
2.2
2.0
0.38
753
3982
(3021440) Promyelocytes/100 leukocytes in Blood
248
659
4.49
86.19
9.2
4.0
%
0.2
0.1
0.26
164
177
(3013115) Eosinophils [#/volume] in Blood
808
4561
3.41
86.09
17.5
5.5
e9/l
0.2
0.2
4.03
760
4004
(42870588) Differential panel, method unspecified - Blood
609
2934
3.21
84.83
17.1
5.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
291
888
4.01
83.70
9.8
7.4
kpa
4.8
5.1
4.32
278
856
(3027801) Oxygen [Partial pressure] in Arterial blood
290
888
4.00
82.95
9.8
7.4
kpa
11.0
13.1
9.14
276
856
(3003396) Base excess in Arterial blood by calculation
288
887
3.97
81.59
9.8
7.4
mmol/l
1.2
0.9
0.85
232
674
(3008536) Aspergillus sp Ab [Presence] in Serum
47
10
48.89
80.42
2.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
115
159
7.90
79.99
1.5
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
88
90
10.48
77.49
1.6
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
202
501
4.65
76.14
6.8
5.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
107
144
8.07
76.11
1.6
1.4
u/ml
91.7
136.8
0.77
18
26
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
793
4647
3.12
74.78
15.9
5.7
umol/l
10.9
11.8
0.93
772
4389
(46235355) HIV 1 and 2 tests - Meaningful Use set
380
1499
3.26
72.47
2.0
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
222
618
4.19
71.77
9.2
4.0
%
0.0
0.6
0.51
132
148
(3027945) Reticulocytes/100 erythrocytes in Blood
290
974
3.62
71.50
6.3
2.4
%
2.0
1.8
1.97
267
858
(1616796) Gas panel - Central venous blood
109
165
7.17
69.79
5.9
3.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
238
712
3.93
69.47
6.0
2.3
e9/l
70.4
69.3
0.15
185
560
(3013650) Neutrophils [#/volume] in Blood by Automated count
835
5175
3.06
68.50
29.5
7.9
e9/l
4.4
4.0
5.40
788
4497
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
55
31
18.55
68.36
3.9
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
55
31
18.55
68.36
3.9
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
55
31
18.55
68.36
3.9
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
55
31
18.55
68.36
3.9
1.6
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
72
67
11.37
67.54
1.4
1.3
g/l
0.4
0.4
0.01
42
43
(3028192) IgG subclass 2 [Mass/volume] in Serum
72
67
11.37
67.54
1.4
1.3
g/l
2.1
2.8
1.50
44
45
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
106
162
7.09
67.23
1.3
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
92
121
8.16
66.59
8.0
3.3
%
1.3
1.2
0.01
83
100
(3001964) Herpes simplex virus Ag [Presence] in Specimen
46
18
26.54
66.30
1.6
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
71
67
11.21
65.97
1.5
1.3
g/l
7.1
6.9
0.05
42
45
(3024980) IgG subclass 4 [Mass/volume] in Serum
89
115
8.28
65.36
1.4
1.6
g/l
0.5
0.8
1.18
55
91
(3002032) Base excess in Venous blood by calculation
242
762
3.73
65.31
9.7
2.9
mmol/l
1.8
1.6
0.19
195
589
(3016502) Oxygen saturation in Arterial blood
249
804
3.65
64.67
10.6
7.9
%
94.1
96.1
3.37
240
777
(4062490)
71
69
10.88
64.65
1.5
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
60
45
13.99
64.28
6.3
3.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
99
150
7.11
63.24
1.4
1.2
u/ml
254.6
245.7
0.10
71
85
(3018418) pH of Serum or Plasma
520
2596
2.78
63.10
11.8
3.4
ph
7.4
7.4
0.46
138
481
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
81
98
8.80
62.72
2.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
81
98
8.80
62.72
2.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
118
216
5.95
62.62
1.9
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
126
246
5.61
62.43
3.7
2.5
u/ml
0.3
0.4
0.10
81
142
(40767503) Oxygen content in Capillary blood by calculation
99
155
6.88
61.31
2.8
2.3
%
15.6
16.3
0.55
51
86
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
740
4456
2.75
61.19
18.2
5.8
mmol/l
1.2
1.2
3.02
619
3741
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
155
371
4.65
60.55
2.6
1.7
g/l
1.6
1.5
0.17
129
318
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
127
257
5.41
60.45
2.6
1.5
titre
368.0
96.0
—
10
10
(3024561) Albumin [Mass/volume] in Serum or Plasma
666
3827
2.68
60.17
11.0
4.5
g/l
33.4
35.9
20.21
629
3562
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
65
62
11.03
59.90
2.0
1.1
u/ml
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
233
761
3.56
59.11
2.4
2.1
nmol/l
360.5
363.4
0.05
223
703
(3021879) Hepatitis B virus core Ab [Presence] in Serum
204
612
3.82
58.74
1.6
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
683
4051
2.61
56.60
15.8
5.2
mmol/l
1.2
1.2
2.95
642
3619
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
45
25
18.67
56.19
3.9
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
45
25
18.67
56.19
3.9
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
45
25
18.67
56.19
3.9
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
122
260
5.11
54.64
1.4
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
217
711
3.51
54.51
17.9
6.6
mmol/l
11.4
9.6
2.96
212
671
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
152
389
4.33
54.33
9.6
9.6
mmol/l
24.3
24.0
0.62
140
360
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
586
3286
2.54
53.85
5.3
3.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
327
1376
2.90
53.57
4.0
2.3
umol/l
11.8
13.4
3.68
314
1275
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
295
1178
3.00
53.13
4.1
2.3
%
22.6
23.5
0.45
259
1025
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
168
473
3.97
52.71
1.9
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
415
1997
2.66
52.19
13.4
4.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
206
671
3.50
52.08
5.1
2.3
g/l
62.7
66.7
7.39
199
599
(3004789) Transferrin [Mass/volume] in Serum or Plasma
307
1267
2.92
51.96
4.0
2.3
g/l
2.2
2.3
6.05
291
1175
(3026782) Osmolality of Urine
383
1782
2.70
51.42
4.2
2.6
mosm/kgh2o
532.1
561.9
2.17
359
1514
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
108
218
5.35
51.39
2.0
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
203
671
3.44
50.05
12.9
7.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
251
945
3.10
49.88
2.0
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
395
1891
2.63
49.81
2.5
1.6
mg/l
1.7
1.2
0.91
333
1413
(3002173) Hemoglobin [Mass/volume] in Arterial blood
216
751
3.29
49.04
11.7
8.3
g/l
115.5
121.2
2.98
210
722
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
79
124
6.75
48.67
2.5
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
397
1926
2.59
48.50
4.2
2.4
e6/l
4.9
4.7
0.16
368
1692
(3032080) INR in Blood by Coagulation assay
625
3731
2.42
48.49
12.9
8.1
inr
1.2
1.2
0.73
211
1053
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
174
533
3.65
48.14
5.1
3.0
kpa
5.0
5.1
0.93
157
495
(3009343) pH of Capillary blood
173
529
3.66
47.98
5.1
3.0
ph
7.4
7.4
2.01
33
63
(3015235) Bicarbonate [Moles/volume] in Capillary blood
100
201
5.34
47.76
3.7
2.9
mmol/l
24.2
24.4
0.18
87
175
(3014576) Chloride [Moles/volume] in Serum or Plasma
271
1092
2.92
47.51
12.3
6.2
mmol/l
104.2
104.5
0.41
260
1063
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
68
93
7.69
47.44
5.5
6.9
mg/l
11.4
11.4
0.01
61
86
(3002582) Erythrocytes [#/volume] in Urine
503
2748
2.44
47.33
5.5
3.1
e6/l
53.7
60.9
0.10
438
2127
(3018677) aPTT in Platelet poor plasma by Coagulation assay
314
1372
2.75
47.19
3.8
1.8
s
30.1
29.5
0.71
308
1327
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
40
25
16.52
47.10
4.1
1.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
94
184
5.46
46.21
4.5
2.8
kpa
8.0
8.4
1.12
85
170
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
65
87
7.85
46.18
1.2
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
502
2783
2.39
45.21
3.5
2.4
u/l
56.7
58.9
0.39
471
2558
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
289
1240
2.76
44.74
1.9
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
163
502
3.60
44.60
5.2
3.1
mmol/l
1.6
1.4
0.26
118
364
(4035726)
211
765
3.14
44.39
1.7
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
40
28
14.75
44.37
4.4
3.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
50
7
74.32
44.33
1.2
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
103
229
4.83
43.71
6.2
3.4
mg/l
1.8
1.5
2.15
98
208
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
65
93
7.34
43.56
2.4
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
463
2516
2.38
43.21
5.3
3.0
e6/l
0.3
0.4
1.11
391
1916
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
47
5
97.83
43.09
1.9
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
85
162
5.57
42.98
8.7
4.2
mmol/l
2.6
2.7
0.17
67
99
(3007164) IgA [Mass/volume] in Serum or Plasma
359
1744
2.52
42.92
2.4
1.3
g/l
2.3
2.4
0.49
280
1059
(3004588) Protein electrophoresis panel - Serum or Plasma
173
570
3.38
42.54
5.0
2.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
248
1010
2.84
42.20
2.1
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
441
2370
2.37
41.97
6.9
2.5
umol/l
2965.4
8234.2
2.10
409
2037
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
134
378
3.87
41.62
10.4
3.1
mmol/l
23.8
23.8
0.01
123
334
(3018095) Leukocytes [#/volume] in Urine
545
3221
2.28
41.27
6.3
3.5
e6/l
53.9
110.7
1.19
452
2302
(3037522) Nuclear Ab [Titer] in Serum
266
1136
2.73
41.23
1.7
1.3
titre
352.4
537.6
1.18
63
229
(3013826) Glucose [Moles/volume] in Serum or Plasma
788
5425
2.34
41.18
11.2
4.1
mmol/l
6.7
6.7
0.07
756
5035
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
107
260
4.42
40.63
1.6
1.5
iu/ml
0.6
0.1
0.58
22
42
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
83
163
5.40
40.60
6.6
3.3
%
60.8
57.7
0.91
83
163
(3037756) Immunofixation for Serum or Plasma
83
165
5.33
40.05
2.1
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
56
77
7.58
38.83
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
32
19
17.28
38.54
3.1
1.9
e6/l
112.0
203.3
—
20
6
(36304419) Bacteria [Presence] in Urine
441
2444
2.28
38.33
5.2
2.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
75
142
5.57
38.15
3.8
2.5
—
—
—
0
0
(3010421) pH of Blood
89
199
4.75
37.44
9.0
3.8
ph
7.4
7.4
1.75
83
159
(40758558) Short blood count panel - Blood
410
2222
2.29
37.43
21.8
5.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
97
235
4.41
36.92
7.3
2.7
ratio
20.2
1.3
—
7
23
(3034860) Kappa light chains.free [Mass/volume] in Serum
98
241
4.34
36.59
7.4
2.7
mg/l
65.9
50.5
0.60
73
199
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
49
62
8.20
36.43
1.4
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
450
2561
2.22
36.23
4.7
2.7
ng/l
2041.8
1129.1
2.96
397
2163
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
97
241
4.29
35.72
7.5
2.7
mg/l
59.3
37.8
0.89
71
200
(40760888) Immunoglobulin light chains.free panel - Serum
80
178
4.75
33.82
7.5
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
446
2588
2.16
33.65
3.8
2.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
184
722
2.83
33.06
9.7
3.2
mmol/l
1.2
1.2
1.29
170
609
(40768795) Lymph node Pathology biopsy report
53
82
6.72
33.01
1.5
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
26
14
18.96
32.68
1.4
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
147
512
3.14
32.66
12.1
7.3
mmol/l
24.5
24.3
0.18
140
476
(3024891) Influenza virus A+B Ag [Presence] in Specimen
77
176
4.61
31.49
1.5
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
73
160
4.80
31.41
1.8
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
124
399
3.35
31.36
16.1
10.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
42
53
8.18
31.26
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
144
510
3.07
31.04
2.2
1.2
u/ml
355.7
216.5
0.47
134
470
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
401
2291
2.13
30.99
2.8
2.0
mg/l
3.3
2.9
2.04
363
1943
(3006184) Hemoglobin [Mass/volume] in Capillary blood
76
175
4.57
30.79
2.4
2.3
g/l
122.9
131.1
1.47
56
139
(3031040) Bacteria [#/volume] in Urine by Automated count
816
6047
2.11
30.74
6.6
4.1
e6/l
45.0
2666.1
1.70
14
91
(3015377) Calcium [Moles/volume] in Serum or Plasma
493
3059
2.04
30.37
7.4
3.1
mmol/l
2.3
2.4
3.71
450
2655
(3021589) Normoblasts [#/volume] in Blood
611
4095
2.01
30.27
27.5
8.4
e9/l
0.0
0.0
0.60
541
3368
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
109
331
3.52
30.16
8.9
5.4
%
1.8
1.6
0.67
102
312
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
918
7153
2.24
29.88
21.8
6.7
u/l
82.6
77.6
2.44
894
6664
(40757373) Influenza virus identified in Isolate
35
7
51.43
29.49
1.3
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
49
80
6.35
28.97
12.8
3.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
472
2930
2.01
28.62
6.2
3.1
u/l
37.9
33.8
0.60
455
2780
(3052851) Hemolysis interference index of Serum or Plasma
87
240
3.83
27.71
4.1
3.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
132
476
2.99
27.48
1.6
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
104
326
3.40
27.35
9.4
5.5
%
0.9
0.9
0.20
97
308
(3037467) Urinalysis macro (dipstick) panel - Urine
840
6420
2.05
27.35
7.1
3.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
24
16
15.29
27.14
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
883
6898
2.09
26.71
8.5
3.7
mm/h
18.2
11.0
23.54
845
6323
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
25
19
13.42
26.31
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
307
1670
2.13
26.30
5.6
3.4
ng/l
176.1
400.5
2.16
255
1300
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
208
963
2.41
26.30
6.0
2.6
umol/l
9.4
9.0
0.09
188
852
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
23
15
15.62
26.29
1.7
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
183
801
2.52
26.13
2.8
2.3
g/l
0.2
0.2
0.11
169
751
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
166
694
2.62
26.07
4.1
2.6
ng/l
184.6
183.1
0.02
154
629
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
39
56
7.17
25.98
2.6
1.1
u/ml
7.4
1.2
0.71
21
22
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
10
20.33
25.83
1.6
2.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
528
3502
1.91
25.60
5.5
3.2
ng/l
132.4
50.8
0.37
415
2400
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
85
249
3.60
24.78
2.1
1.5
g/l
0.2
0.2
0.15
79
237
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
87
260
3.53
24.61
2.1
1.5
g/l
1.2
1.2
0.16
82
245
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
306
3.32
24.56
6.1
1.9
g/l
7.7
7.3
0.93
69
228
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
306
3.32
24.56
6.0
1.9
g/l
3.6
3.7
0.14
67
220
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
306
3.32
24.56
6.1
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
77
215
3.76
24.08
1.2
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
43
75
5.91
23.79
9.6
2.7
%
60.1
53.1
0.95
28
47
(3044640) Blood type and Crossmatch panel - Blood
454
2920
1.90
23.72
5.1
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
201
958
2.32
23.62
5.5
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
617
4384
1.85
23.39
8.4
3.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
284
3.35
23.38
5.8
1.9
g/l
9.5
10.5
0.64
77
237
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
149
622
2.60
23.37
6.3
3.5
ng/l
106.4
81.1
2.63
132
545
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
73
203
3.77
22.96
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
28
32
8.94
22.48
1.4
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
120
470
2.73
21.32
2.3
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
538
3739
1.80
21.27
3.1
2.2
nmol/l
76.8
77.4
0.22
502
3301
(3042733) HLA Ab [Presence] in Serum
21
17
12.56
21.23
4.2
4.9
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
76
229
3.48
21.22
2.0
2.2
mg/l
11.9
11.3
0.21
70
206
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
11
16.60
21.15
1.8
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
11
16.60
21.15
1.8
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
11
16.60
21.15
1.8
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
77
238
3.39
20.66
11.1
7.0
mmol/l
1.4
1.3
0.36
71
209
(3024471) HLA-A [Type]
23
23
10.18
20.31
1.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
257
1429
2.02
20.14
4.7
2.8
e6/l
1.9
1.9
0.00
165
794
(3024932) HLA-DR beta [Type]
22
21
10.65
20.04
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
270
1530
1.99
20.04
4.3
2.6
e6/l
1.1
1.1
0.01
176
889
(40765096) Chromosome analysis panel by Banding
24
26
9.40
20.03
1.2
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
364
2281
1.86
19.92
8.9
3.5
%
87.8
89.6
0.68
357
2227
(3015171) Extractable nuclear Ab [Units/volume] in Serum
91
318
3.02
19.92
1.5
1.3
u/ml
0.2
0.6
—
5
24
(3035350) Ketones [Presence] in Urine by Test strip
617
4520
1.76
19.90
5.5
3.4
estimate
0.0
0.0
0.00
159
845
(3009261) Glucose [Presence] in Urine by Test strip
621
4574
1.75
19.50
5.5
3.4
estimate
0.0
0.0
0.50
156
821
(3022313) Gas panel - Capillary blood
103
390
2.80
19.49
5.9
3.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
52
128
4.20
19.34
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
614
4517
1.74
19.29
7.2
4.6
estimate
0.0
0.0
0.50
164
856
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
85
291
3.07
19.28
6.4
1.9
g/l
3.4
3.0
2.16
68
223
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
30
45
6.81
19.19
1.7
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
30
45
6.81
19.19
1.7
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
99
371
2.82
19.10
1.9
2.0
u/l
41.1
38.9
0.38
92
327
(3001122) Ferritin [Mass/volume] in Serum or Plasma
549
3931
1.74
18.85
4.6
2.6
ug/l
312.2
129.3
4.01
520
3609
(3020891) Body temperature
95
354
2.83
18.52
6.7
4.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
23
27
8.67
18.06
2.0
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
19
17
11.34
18.02
1.8
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
39
81
4.94
17.87
1.5
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
34
63
5.53
17.67
1.4
1.1
titre
230.0
93.8
—
9
13
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
351
2250
1.79
17.44
4.5
2.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
53
144
3.81
17.24
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
729
5726
1.71
17.17
3.6
2.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
160
788
2.19
17.10
3.9
2.1
u/l
37.4
97.3
0.50
143
686
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
157
773
2.19
16.78
2.3
2.2
ug/l
7.3
7.4
0.02
138
682
(40768804) Tissue Pathology biopsy report
515
3717
1.68
16.49
2.3
2.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
279
1693
1.85
16.48
1.9
1.7
nmol/l
1220.5
1182.5
0.24
217
1251
(3023199) Leukocytes [#/volume] in Pleural fluid
36
75
4.92
16.44
1.6
1.3
e6/l
2695.5
1510.7
0.81
31
56
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
83
308
2.82
16.30
5.4
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
46
118
4.01
16.21
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
276
1681
1.84
16.06
4.3
2.8
mmol/l
2.5
2.4
0.46
247
1469
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
36
79
4.67
15.47
4.1
2.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
78
291
2.80
15.17
3.5
2.0
ug/l
215.3
411.0
0.66
72
276
(3011436) Histone Ab [Units/volume] in Serum
15
12
12.65
15.16
1.0
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
172
916
2.03
14.89
4.4
4.0
ug/l
15.2
23.4
0.25
137
753
(3028308) Erythrocytes [#/volume] in Pleural fluid
31
63
5.03
14.57
1.7
1.3
e6/l
43774.5
159177.4
0.66
23
42
(3039000) Anion gap in Blood
54
167
3.34
14.50
12.4
8.6
mmol/l
11.7
11.2
0.43
49
151
(3018572) Chloride [Moles/volume] in Blood
54
167
3.34
14.50
12.4
8.6
mmol/l
104.5
105.8
1.29
49
151
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
72
264
2.84
14.46
5.4
1.9
g/l
1.3
0.9
0.22
67
224
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
33
72
4.69
14.29
1.5
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
75
284
2.75
14.19
3.6
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
393
2729
1.66
14.05
3.0
2.0
u/l
132.5
226.0
2.45
370
2561
(3035880) pH of Pleural fluid
21
30
7.11
14.01
1.3
1.2
—
—
—
0
0
(4015189)
15
14
10.84
13.77
3.7
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
73
277
2.74
13.76
2.3
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
35
83
4.31
13.69
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
48
143
3.46
13.67
1.2
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
150
785
2.04
13.58
5.6
3.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
43
120
3.68
13.49
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
25
45
5.65
13.40
2.4
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
50
156
3.30
13.25
1.4
1.2
u/l
96.9
23.4
1.88
44
140
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
143
743
2.05
13.19
4.4
2.7
ml/min/173m2
57.8
66.1
1.48
54
296
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
56
188
3.08
13.16
1.7
1.5
e6/l
51.1
13.5
0.59
47
155
(3045788) Cell count panel - Pleural fluid
28
58
4.92
12.89
1.6
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
309
2054
1.68
12.89
4.9
3.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
14
13
10.89
12.87
1.7
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
23
40
5.84
12.76
5.3
3.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
35
88
4.07
12.70
1.3
1.6
mosm/kgh2o
278.3
279.9
0.11
30
67
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
31
6.54
12.39
3.2
3.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
37
99
3.83
12.34
1.6
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
24
45
5.42
12.33
2.4
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
44
133
3.40
12.27
1.5
1.3
mmol/l
72.1
58.8
1.14
38
113
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
81
344
2.45
12.16
6.6
3.1
mmol/l
24.7
24.7
0.02
75
318
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
91
3.93
12.14
1.2
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
16
6
26.99
12.06
1.4
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
31
74
4.27
12.04
5.3
2.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
13
12
10.94
11.97
1.9
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
353
2468
1.61
11.91
5.6
3.7
estimate
0.0
0.0
0.88
141
824
(3023183) Ammonium ion [Moles/volume] in Plasma
51
172
3.05
11.91
3.1
3.5
umol/l
33.4
38.2
0.80
44
143
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
20
8.10
11.90
1.9
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
9
19.14
11.60
4.1
7.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
16
7
23.14
11.58
2.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
50
171
3.01
11.41
11.2
2.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
36
100
3.68
11.40
1.2
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
38
110
3.54
11.33
5.4
2.0
pg
32.2
32.7
0.31
38
110
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
14
16
8.84
11.13
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
14
16
8.84
11.13
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
14
16
8.84
11.13
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
14
16
8.84
11.13
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
60
231
2.68
11.02
1.6
1.4
—
—
—
0
0
(3019977) pH of Arterial blood
21
39
5.46
10.90
1.9
2.5
ph
7.4
7.4
—
9
9
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
467
3537
1.53
10.87
5.5
3.6
—
—
—
0
0
(3017704) Immunofixation for Urine
23
47
4.97
10.76
2.6
1.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
66
270
2.53
10.74
7.0
4.1
mmol/l
3.9
3.9
0.11
60
251
(3045716) Anion gap in Serum or Plasma
24
51
4.78
10.74
2.9
1.7
mmol/l
8.6
10.1
0.86
15
40
(3021960) Folate [Moles/volume] in Serum or Plasma
324
2269
1.59
10.67
1.9
1.5
nmol/l
18.8
21.0
1.81
285
1927
(3012441) Differential panel - Pleural fluid
29
73
4.05
10.53
1.7
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
53
197
2.77
10.43
2.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
46
159
2.97
10.32
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
63
257
2.53
10.32
1.7
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
26
63
4.20
9.93
4.9
2.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
734
6177
1.49
9.84
4.9
3.0
u/l
68.0
48.1
4.70
700
5755
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1040
9476
1.78
9.80
47.5
11.6
mg/l
27.2
22.5
5.40
951
7329
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
28
73
3.90
9.71
1.1
1.2
u/l
68.6
57.2
0.43
23
53
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
38
122
3.18
9.67
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
84
403
2.17
9.53
1.4
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
16
26
6.22
9.47
1.7
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
61
4.16
9.46
1.2
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
183
1146
1.71
9.27
21.9
23.7
inr
1.3
1.3
0.07
32
159
(3004451) EKG impression Narrative
21
46
4.63
9.08
1.7
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
5
24.21
8.92
2.6
4.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
13
8.53
8.47
5.7
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
19
6.91
8.45
1.4
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
16
7.57
8.42
1.3
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
18
37
4.92
8.37
1.7
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
340
2517
1.49
8.37
5.1
3.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
72
3.67
8.31
1.7
1.4
%
31.4
27.3
0.19
16
49
(3044290) Cell count panel - Cerebral spinal fluid
43
162
2.72
8.29
1.8
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
17
34
5.06
8.15
2.1
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
191
1250
1.63
8.13
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
27
78
3.52
8.12
1.1
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
11
9.16
8.09
1.1
1.0
%
89.4
108.6
—
10
11
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
11
9.16
8.09
1.1
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
47
4.31
7.95
1.8
1.6
u/l
7.7
3.7
0.28
14
22
(3014765) Yersinia sp identified in Stool by Organism specific culture
59
264
2.30
7.95
1.3
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
348
2617
1.47
7.83
1.6
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
25
71
3.58
7.72
1.8
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
25
71
3.58
7.72
5.4
3.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
59
268
2.26
7.68
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
38
141
2.75
7.56
1.5
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
38
141
2.75
7.56
1.5
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
39
147
2.71
7.54
6.9
2.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
40
153
2.67
7.51
1.3
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
482
3871
1.41
7.51
2.3
1.9
pmol/l
91.5
94.4
0.72
293
1980
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
20
50
4.05
7.36
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
20
50
4.05
7.36
1.1
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
37
139
2.72
7.20
1.4
1.2
u/ml
1.8
1.6
0.18
12
42
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
57
263
2.23
7.17
1.3
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
52
231
2.31
7.15
1.7
1.2
u/ml
8.9
2.3
—
5
17
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
39
4.41
6.97
2.5
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
39
4.41
6.97
2.5
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
29
97
3.04
6.95
1.8
1.6
%
61.4
62.7
0.05
17
64
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
35
4.62
6.94
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
50
222
2.31
6.89
1.3
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
52
235
2.27
6.88
1.8
1.2
u/ml
6.5
8.5
—
8
32
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
18
44
4.14
6.83
1.1
1.2
u/l
88.3
75.3
0.36
18
39
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
53
3.82
6.82
1.1
1.1
—
—
—
0
0
(3013512) EKG study
358
2770
1.42
6.74
5.1
3.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
31
110
2.87
6.72
1.5
1.3
—
66.5
—
0
6
(3016750) Collection duration of Urine
20
54
3.75
6.65
1.6
2.1
min
532.9
500.3
0.82
15
40
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
11
9
12.32
6.58
1.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
46
203
2.32
6.44
1.9
1.8
e6/l
11347.1
15501.1
0.45
38
148
(3019832) Treponema pallidum Ab [Presence] in Serum
123
763
1.68
6.42
1.5
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
124
772
1.68
6.38
4.9
3.3
—
—
—
0
0
(4010399)
101
596
1.76
6.31
1.8
1.4
—
—
—
0
0
(3000492) Spirometry study
133
846
1.64
6.30
2.2
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
16
38
4.25
6.30
2.1
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
216
1537
1.50
6.27
1.5
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
871
7857
1.41
6.18
51.0
15.0
%
14.6
13.6
34.57
866
7675
(3007566) Smooth muscle Ab [Titer] in Serum
50
233
2.20
6.17
1.3
1.2
titre
71.1
55.9
—
9
17
(3034770) Mitochondria Ab [Titer] in Serum
52
247
2.16
6.13
1.3
1.2
—
1427.8
—
0
9
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
39
4.14
6.10
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
29
105
2.81
6.08
1.5
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
23
73
3.19
6.04
1.8
2.2
ml
617.8
653.8
0.17
18
47
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
15
35
4.33
6.03
2.1
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
32
123
2.65
6.00
2.7
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
67
353
1.95
5.99
3.5
3.2
u/ml
442.5
11146.9
0.77
60
304
(3016018) Differential panel - Cerebral spinal fluid
25
84
3.02
5.98
1.5
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
87
500
1.80
5.95
3.2
3.5
pmol/l
4.2
4.6
3.77
75
439
(3009214) Lutropin [Units/volume] in Serum or Plasma
50
238
2.15
5.87
1.5
1.5
u/l
9.1
9.1
0.01
36
197
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
143
2.49
5.82
1.3
1.1
u/ml
3.2
2.9
0.15
14
57
(3017732) Neutrophils [#/volume] in Blood
97
582
1.73
5.73
3.5
3.0
e9/l
4.2
3.9
0.59
76
444
(4268621)
26
92
2.87
5.70
2.4
2.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
17
46
3.73
5.65
1.2
1.8
u/l
6.9
6.4
0.10
12
39
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
212
1533
1.47
5.65
1.4
1.3
iu/ml
45.0
33.8
0.47
73
470
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
7
12.94
5.58
1.1
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
31
122
2.58
5.57
2.7
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
29
4.52
5.52
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
81
470
1.78
5.38
2.4
2.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
20
63
3.21
5.33
1.5
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
20
63
3.21
5.33
1.5
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
20
63
3.21
5.33
1.5
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1043
9803
1.52
5.31
45.5
14.1
mmol/l
138.8
139.7
21.42
1028
9524
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
203
1476
1.45
5.24
1.3
1.3
u/ml
18.7
12.0
0.42
63
555
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
80
2.91
5.21
1.4
1.4
e6/l
10891.3
130988.7
0.84
15
58
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
20
64
3.16
5.20
1.5
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
20
64
3.16
5.20
1.5
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
20
64
3.16
5.20
1.5
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1045
9834
1.52
5.19
46.1
14.2
mmol/l
4.0
4.0
0.54
1027
9537
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
59
3.26
5.18
1.2
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
18
54
3.37
5.17
1.3
1.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
12
27
4.48
5.04
3.1
2.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
30
123
2.48
4.99
2.8
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
261
2003
1.39
4.96
1.7
1.7
pmol/l
38426398.7
36380683.6
0.02
216
1641
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
16
46
3.51
4.90
1.5
1.4
—
76.3
—
0
8
(3044889) 12 lead EKG panel
745
6668
1.31
4.83
5.6
3.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
153
1070
1.49
4.80
3.6
2.3
ug/g
207.1
127.2
1.40
130
837
(3022145) Colonoscopy Study observation
150
1055
1.48
4.58
1.3
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
5
14.07
4.58
1.4
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
13
34
3.85
4.54
7.9
3.0
u/l
246.3
202.2
0.61
13
34
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
8
10.06
4.52
12.0
11.3
mmol/l
4.8
7.3
—
8
8
(3025468) Yersinia sp identified in Specimen by Organism specific culture
29
123
2.39
4.51
2.8
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
29
123
2.39
4.51
2.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
29
124
2.37
4.44
2.8
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
26
106
2.49
4.40
1.5
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
6
11.73
4.28
1.3
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
6
11.73
4.28
1.6
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
6
11.73
4.28
1.3
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
30
133
2.29
4.24
1.4
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
13
6.97
4.16
2.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
164
1196
1.43
4.15
1.3
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
23
4.38
4.09
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
63
2.89
4.07
18.7
1.8
%
9.2
11.4
1.77
18
63
(3004716) Salmonella sp identified in Stool by Organism specific culture
74
456
1.66
4.03
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
913
9688
0.75
4.01
5.2
4.9
mmol/l
2.7
2.7
1.89
825
8882
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
38
190
2.03
4.01
1.8
1.2
u/ml
51.1
55.9
—
7
16
(3027456) Digoxin [Moles/volume] in Serum or Plasma
34
163
2.12
4.00
2.2
3.0
nmol/l
0.9
0.8
0.26
27
126
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
28
3.96
3.98
1.4
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
11
28
3.96
3.98
2.4
4.8
umol/l
111.2
116.2
—
6
17
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
53
3.05
3.97
4.4
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
13
38
3.45
3.91
2.3
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
24
4.19
3.89
1.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
24
4.19
3.89
1.7
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
43
229
1.91
3.82
1.2
1.3
miu/ml
174.6
232.2
0.45
14
108
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
34
3.56
3.77
1.7
2.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
74
465
1.63
3.75
5.9
3.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
30
3.69
3.64
1.0
1.0
—
—
—
0
0
(4027681)
16
56
2.88
3.63
1.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
62
2.77
3.59
1.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
26
118
2.23
3.53
5.6
2.1
mmol/l
4.3
4.1
1.26
26
118
(3036048) Francisella tularensis Ab [Titer] in Serum
9
17
5.33
3.51
1.1
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
43
236
1.85
3.51
2.2
2.4
ug/min
146.9
95.7
0.46
28
143
(3019768) Coxiella burnetii Ab [Presence] in Serum
6
6
10.04
3.50
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
49
281
1.78
3.48
1.7
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
45
252
1.82
3.45
1.3
1.4
ug/g
256.3
292.2
0.41
22
150
(3044242) Glucose [Moles/volume] in Arterial blood
14
47
3.00
3.42
1.6
1.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
17
64
2.68
3.40
1.4
1.1
—
68.3
—
0
7
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
76
2.52
3.39
1.3
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
10
27
3.73
3.36
1.1
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
48
2.94
3.30
1.6
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
25
115
2.20
3.30
5.8
2.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
43
3.05
3.25
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
922
8663
1.29
3.25
40.2
13.2
%
38.4
40.1
6.44
617
6211
(3032057) Clostridioides difficile [Presence] in Stool
9
19
4.76
3.24
2.6
2.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
18
72
2.52
3.22
4.3
3.1
u/ml
40.2
22.5
0.72
18
72
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
15
5.36
3.19
2.5
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
11
6.39
3.18
1.3
1.2
ng/l
178.1
122.9
—
7
11
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
13
44
2.98
3.14
1.2
1.1
ratio
1.1
1.1
—
7
16
(3035285) Chloride [Moles/volume] in Venous blood
25
118
2.14
3.11
5.8
2.1
mmol/l
105.6
105.7
0.03
25
118
(3019150) Specific gravity of Urine by Refractometry
249
2026
1.29
3.08
5.8
3.7
kg/l
1.0
1.0
0.72
33
286
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1061
10187
1.39
3.06
26.2
9.5
u/l
27.9
26.6
0.69
1040
9790
(3037121) Protein [Mass/volume] in Urine
54
332
1.66
3.03
3.9
3.4
g/l
0.4
0.2
0.39
37
135
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
27
133
2.05
3.03
3.2
2.3
u/ml
729.8
37.3
0.46
27
127
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
5
10.03
2.98
1.4
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
5
10.03
2.98
1.4
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
42
242
1.76
2.97
6.6
4.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
904
9516
0.79
2.91
4.9
4.4
mmol/l
4.5
4.6
2.01
824
8771
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
22
102
2.18
2.88
1.2
1.1
%
99.5
96.9
0.19
22
97
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
45
268
1.71
2.85
3.6
2.2
u/l
5612.8
2444.3
0.48
20
113
(3034988) Calcium [Moles/volume] in Capillary blood
8
18
4.47
2.79
2.4
2.2
mmol/l
1.2
1.2
—
8
18
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
898
9448
0.80
2.78
4.8
4.4
mmol/l
1.4
1.4
3.87
818
8660
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
23
3.93
2.77
1.0
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
6
8.36
2.75
1.2
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
14
5.02
2.73
1.0
1.9
umol/l
15.3
16.4
—
7
14
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
19
4.23
2.68
1.1
1.4
—
—
—
0
0
(4198724)
10
32
3.14
2.65
7.1
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
16
69
2.34
2.49
1.6
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
57
2.47
2.45
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
138
1.90
2.42
1.2
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
12
5.02
2.40
7.3
2.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
7
17
4.14
2.36
2.4
2.2
mmol/l
1.2
1.2
—
7
17
(3035933) Granulocytes/100 leukocytes in Blood
9
28
3.23
2.31
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
59
2.39
2.29
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
18
85
2.13
2.29
1.6
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
298
3443
0.82
2.29
3.5
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
35
567
0.61
2.28
1.8
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
47
2.57
2.27
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
13
4.63
2.27
6.8
2.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
18
86
2.11
2.23
1.6
1.2
nmol/l
1.3
1.5
0.35
18
75
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
58
837
0.68
2.23
1.8
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
762
7135
1.19
2.17
4.6
3.8
pmol/l
14.8
14.8
0.21
699
6444
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
14
4.30
2.15
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
19
3.70
2.15
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
102
1.98
2.11
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
75
2.15
2.09
1.2
1.3
mmol/l
11.0
11.6
—
9
18
(3045414) Leukocytes [Presence] in Urine
59
408
1.47
2.07
2.6
1.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
51
344
1.50
2.02
1.6
1.4
iu/l
27.4
27.3
0.01
39
298
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
38
2.65
2.01
1.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1031
9964
1.26
2.00
33.5
11.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
81
599
1.38
1.98
3.7
2.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
335
2946
1.19
1.96
5.4
3.9
mg/mmol
11.2
7.2
1.43
245
1851
(3009508) Creatinine [Moles/volume] in Urine
338
2975
1.19
1.96
5.0
3.1
mmol/l
7.4
7.8
1.03
294
2477
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
27
2.98
1.93
2.0
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
27
2.98
1.93
2.0
2.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
235
2001
1.22
1.93
1.3
1.3
u/ml
0.9
1.4
0.80
63
530
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
59
415
1.44
1.92
3.0
3.2
u/ml
237.3
46.0
0.44
59
399
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
20
106
1.90
1.91
2.3
2.0
mg/l
31.6
22.3
—
8
26
(3012516) Albumin [Mass/volume] in Urine
319
2799
1.19
1.91
5.0
3.2
mg/l
1299.5
219.5
1.83
236
1763
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
894
9313
0.84
1.85
5.1
4.5
mmol/l
6.1
5.9
1.57
821
8415
(3013293) Extractable nuclear Ab [Presence] in Serum
5
12
4.18
1.82
1.8
1.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
94
1.93
1.80
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
33
209
1.60
1.75
3.3
2.1
—
—
—
0
0
(4306422)
23
133
1.74
1.70
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
185
2179
0.82
1.70
2.4
3.1
ug/l
0.7
0.8
0.21
119
1415
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
261
2978
0.84
1.69
3.6
4.4
%
22.3
21.3
0.40
123
1438
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
25
2.81
1.65
1.1
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
14
3.58
1.61
1.4
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
26
2.70
1.58
2.6
2.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
18
99
1.83
1.57
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
77
589
1.33
1.56
1.2
1.2
iu/ml
113.0
146.7
0.41
29
245
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
64
2.04
1.54
1.8
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
44
2.28
1.53
2.0
2.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
205
0.48
1.52
1.3
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
27
2.60
1.51
1.1
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
135
1116
1.24
1.50
2.0
1.8
%
1.6
1.5
1.00
117
985
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
65
2.01
1.49
1.8
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
87
1.85
1.46
1.1
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
151
0.46
1.44
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
151
0.46
1.44
1.1
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
22
2.74
1.43
7.5
7.9
—
—
—
0
0
(3019225) pH of Specimen
114
932
1.25
1.41
7.7
3.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
9
40
2.26
1.40
2.7
2.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
29
2.42
1.39
1.3
1.3
ug/l
9.7
9.3
—
7
29
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
74
1.90
1.39
2.4
1.8
u/field
0.8
2.1
—
8
29
(3028707) Methadone [Presence] in Urine by Screen method
21
127
1.67
1.37
8.7
2.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
17
2.95
1.36
6.6
8.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
19
112
1.71
1.36
1.6
1.5
u/l
26.2
24.2
0.09
13
91
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
24
2.51
1.30
7.5
7.9
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
8
34
2.36
1.29
1.0
1.1
%
105.3
93.3
—
8
28
(3021387) Prolactin [Units/volume] in Serum or Plasma
41
294
1.41
1.27
1.8
1.5
mu/l
290.6
306.1
0.12
34
271
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
157
0.51
1.25
1.1
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
36
2.23
1.24
1.1
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
36
2.23
1.24
1.1
1.1
miu/ml
1837.6
1705.5
—
8
36
(3006270) Folate [Moles/volume] in Blood
13
70
1.87
1.24
1.1
1.1
nmol/l
317.5
372.1
—
7
59
(4211845)
9
45
2.01
1.23
4.1
3.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
49
2.05
1.22
2.3
1.2
nmol/l
139.9
137.0
—
10
49
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
19
2.64
1.21
1.0
1.1
u/ml
18.7
26.9
—
5
19
(3017446) Testosterone [Moles/volume] in Serum or Plasma
98
806
1.24
1.18
2.8
2.2
nmol/l
13.0
13.0
0.00
87
718
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
39
2.06
1.15
5.9
2.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
19
118
1.62
1.15
1.5
1.5
nmol/l
0.4
0.3
0.35
14
95
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
895
8658
1.14
1.13
5.4
4.5
mu/l
2.0
2.1
0.21
818
7861
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
167
1.51
1.13
1.3
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
40
2.01
1.12
4.5
3.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
29
201
1.45
1.10
3.6
1.6
nmol/l
1.4
0.8
0.98
24
166
(3009466) Valproate [Moles/volume] in Serum or Plasma
19
120
1.59
1.09
4.4
4.9
umol/l
363.5
364.4
0.01
14
102
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
928
9010
1.14
1.06
35.7
11.6
ml/min/173m2
78.1
81.0
3.15
828
7394
(3001019) Free T4 and TSH panel - Serum or Plasma
35
471
0.74
1.01
1.6
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
236
0.63
0.98
1.1
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
830
8022
1.11
0.97
52.3
16.0
g/l
330.6
333.1
11.08
823
7962
(21494755) Public health laboratory ask at order entry panel
73
883
0.82
0.93
1.4
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
56
1.79
0.88
4.0
8.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
30
2.00
0.87
2.2
2.2
—
—
—
0
0
(4094501)
18
263
0.68
0.86
1.1
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
31
1.94
0.84
4.7
2.5
ug/l
19.6
299.4
—
6
25
(3043410) Blood group antigens tested for on Red Blood Cells
6
31
1.94
0.84
3.5
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
155
1.43
0.81
1.0
1.1
iu/ml
0.9
99.2
—
5
43
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
58
1.73
0.79
1.3
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
861
8836
0.91
0.79
7.2
5.7
mmol/mol
40.5
39.6
1.98
798
8148
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
890
9117
0.91
0.78
4.5
3.9
mmol/l
1.4
1.3
4.73
809
8298
(40768793) Breast Pathology biopsy report
27
200
1.36
0.76
1.1
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
91
1.54
0.75
1.1
1.1
u/ml
3.2
4.3
—
7
34
(3045424) Erythrocytes [Presence] in Urine
22
158
1.40
0.74
1.5
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
24
2.09
0.74
1.8
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
96
835
1.16
0.70
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
205
0.68
0.70
1.3
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
41
1.71
0.70
2.4
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
228
0.70
0.70
1.6
1.5
—
—
—
0
0
(4024509)
12
77
1.56
0.68
1.6
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
42
1.67
0.68
2.4
2.5
ug/l
0.4
1.3
—
7
37
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
107
1211
0.87
0.67
4.1
4.5
%
29.5
31.9
1.40
76
797
(3008898) HLA-B27 [Presence]
39
312
1.26
0.67
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
136
1220
1.13
0.65
17.7
6.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
137
1.39
0.65
1.2
1.1
u/ml
2.5
1.9
—
10
55
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
95
1.48
0.64
1.4
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
29
1.73
0.64
3.0
1.7
—
—
—
0
0
(4281824)
13
87
1.50
0.63
1.2
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
12
79
1.52
0.62
1.4
1.3
ug/l
1.5
3.0
1.14
12
67
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
188
0.69
0.62
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
188
0.69
0.62
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
188
0.69
0.62
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
188
0.69
0.62
1.2
1.4
—
—
—
0
0
(44813793)
10
63
1.59
0.62
1.0
1.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
12
80
1.51
0.60
3.4
1.9
nmol/l
23.9
20.5
0.33
12
75
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
53
1.51
0.58
1.5
1.2
ug/l
3.7
6.0
—
8
43
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
98
1.43
0.56
1.1
1.0
u/ml
1.1
2.9
—
8
34
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
94
1055
0.88
0.55
1.7
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
26
204
1.28
0.54
5.7
3.2
mg/l
35.4
25.8
0.56
20
125
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
27
213
1.27
0.54
2.6
2.0
pmol/l
229.3
214.8
0.19
27
199
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
6
39
1.54
0.53
1.2
1.1
—
6.6
—
0
8
(3023511) Choriogonadotropin [Units/volume] in Urine
19
143
1.33
0.52
1.4
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
367
0.81
0.49
3.1
1.8
mg/l
14.1
2.3
0.92
20
259
(3024731) MCV [Entitic volume]
1079
10677
1.11
0.49
58.7
18.2
fl
91.7
91.0
5.43
1069
10504
(3026361) Erythrocytes [#/volume] in Blood
1079
10678
1.11
0.48
58.9
18.2
e12/l
4.3
4.5
40.62
1058
10356
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
46
1.52
0.48
1.3
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
119
1.35
0.48
1.0
1.0
u/ml
1.8
2.5
—
6
48
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
47
1.49
0.47
21.3
19.6
nmol/l
1327.1
1399.5
—
7
47
(3049717) Cytology report of Urine Cyto stain
46
392
1.18
0.47
2.1
2.8
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
12
85
1.42
0.47
1.2
1.0
u/ml
0.0
0.6
—
7
21
(3000963) Hemoglobin [Mass/volume] in Blood
1079
10681
1.11
0.47
59.3
18.3
g/l
127.7
136.6
52.58
1069
10506
(4146454)
8
118
0.68
0.46
2.3
2.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1078
10674
1.11
0.45
59.1
18.2
e9/l
241.9
246.7
1.28
1059
10389
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
130
1.31
0.44
1.2
1.0
u/ml
4.2
6.3
—
10
64
(3035941) MCH [Entitic mass]
1078
10677
1.10
0.43
58.7
18.1
pg
30.4
30.4
0.11
1068
10503
(3037556) Urate [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
1.2
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
34
285
1.20
0.43
5.9
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
158
1.27
0.42
1.6
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1078
10680
1.10
0.41
59.0
18.2
e9/l
7.6
6.6
8.84
1056
10361
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
17
0.00
0.40
0.0
2.2
—
3.3
—
0
7
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
10
71
1.41
0.39
1.9
1.3
—
74.7
—
0
6
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
106
1.32
0.39
1.1
1.3
nmol/l
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
42
484
0.86
0.39
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
124
1.29
0.38
1.3
1.1
u/ml
0.4
2.8
—
10
48
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
36
1.39
0.38
3.6
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
36
1.39
0.38
2.0
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
108
1.30
0.35
1.1
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
172
1.22
0.34
1.6
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
47
1.28
0.32
1.0
1.1
iu/ml
72.3
220.5
—
6
47
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
97
0.72
0.31
1.3
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
55
1.27
0.30
1.1
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
111
0.72
0.28
1.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
10
76
1.32
0.28
1.3
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
93
866
1.08
0.27
2.0
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
35
310
1.13
0.26
5.8
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
33
292
1.13
0.25
1.4
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
35
311
1.13
0.25
5.8
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
76
1.19
0.24
2.0
1.9
—
—
—
0
0
(4034850)
28
318
0.88
0.24
16.7
9.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
339
0.88
0.24
1.6
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
35
312
1.13
0.24
5.8
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
121
1277
0.94
0.24
1.7
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
39
1.28
0.23
1.8
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
31
347
0.89
0.22
1.7
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
43
1.16
0.21
5.2
14.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
89
1.24
0.21
2.2
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
34
308
1.11
0.19
5.9
1.8
—
—
—
0
0
(1002224) Polysomnography panel
34
374
0.91
0.19
1.0
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
8
72
1.11
0.16
1.1
1.0
mg/l
328.6
283.1
—
8
63
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
29
264
1.10
0.15
1.6
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
57
596
0.95
0.10
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
365
3697
0.98
0.09
4.4
5.1
ug/l
6.1
3.3
0.38
323
3302
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
46
1.09
0.09
1.0
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
203
1.09
0.09
8.5
2.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
73
705
1.04
0.09
1.2
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
122
0.90
0.07
1.4
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
98
958
1.03
0.06
2.1
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
321
0.96
0.03
1.9
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
46
471
0.98
0.03
1.5
1.9
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
11
102
1.08
0.03
1.5
1.3
pmol/l
480.9
312.5
1.05
11
81
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
38
371
1.03
0.02
1.5
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
242
1.03
0.02
7.5
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
167
0.96
0.01
1.6
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
258
2587
1.00
0.00
1.8
1.6
mmol/l
1.6
1.4
2.65
220
2151
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
144
0.97
0.00
2.1
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
143
0.98
0.00
1.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.2
—
0
5
(4038314)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
568.2
—
0
5
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
8.6
—
0
5
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
2.5
—
0.5
—
0
8
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
6
64
0.94
0.00
1.5
2.1
ug/l
3.9
3.3
—
6
57
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
6
64
0.94
0.00
1.5
2.1
ug/l
2.1
1.9
—
6
56
(3032773) Endomysium IgG Ab [Titer] in Serum
7
79
0.89
0.00
1.0
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
99
0.91
0.00
1.7
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_PNEUMONONBACT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_PNEUMONONBACT | 3.241 [2.53, 4.15] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.776 |
During the follow-up period (1.1.1998 — 31.12.2019), 589 out of 1540 females with J10_PNEUMONONBACT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_PNEUMONONBACT | 3.747 [2.93, 4.8] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 889 out of 1940 males with J10_PNEUMONONBACT died.
Mortality risk
Mortality risk for people of age
years, who have J10_PNEUMONONBACT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.373% | 0.717% |
| 5 | 2.086% | 3.691% |
| 10 | 5.952% | 9.123% |
| 15 | 10.65% | 17.786% |
| 20 | 18.24% | 28.582% |
Relationships between endpoints
↥Index endpoint: J10_PNEUMONONBACT – Pneumonia due to other infectious organisms, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data